期刊
JOURNAL OF GENERAL INTERNAL MEDICINE
卷 32, 期 12, 页码 1315-1322出版社
SPRINGER
DOI: 10.1007/s11606-017-4150-7
关键词
COPD; electronic cigarette; lung function; tobacco
资金
- NIH/NHLBI [HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C]
- AstraZeneca
- Bellerophon Therapeutics
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Chiesi Farmaceutici SpA
- Forest Research Institute, Inc.
- GSK
- Grifols Therapeutics, Inc.
- Ikaria, Inc.
- Nycomed GmbH
- Takeda Pharmaceutical Company
- Novartis Pharmaceuticals Corporation
- Regeneron Pharmaceuticals, Inc.
- Sanofi
- National Heart, Lung, and Blood Institute [R01 HL089897, R01 HL089856]
- COPD Foundation
Electronic cigarettes (e-cigarettes) are battery-operated nicotine-delivery devices used by some smokers as a cessation tool as well as by never smokers. To determine the usage of e-cigarettes in older adults at risk for or with chronic obstructive pulmonary disease (COPD). Prospective cohorts. COPDGene (N = 3536) and SPIROMICS (N = 1060) subjects who were current or former smokers aged 45-80. Participants were surveyed to determine whether e-cigarette use was associated with longitudinal changes in COPD progression or smoking habits. From 2010 to 2016, participants who had ever used e-cigarettes steadily increased to 12-16%, but from 2014 to 2016 current use was stable at similar to 5%. E-cigarette use in African-Americans (AA) and whites was similar; however, AA were 1.8-2.9 times as likely to use menthol-flavored e-cigarettes. Current e-cigarette and conventional cigarette users had higher nicotine dependence and consumed more nicotine than those who smoked only conventional cigarettes. E-cigarette users had a heavier conventional cigarette smoking history and worse respiratory health, were less likely to reduce or quit conventional cigarette smoking, had higher nicotine dependence, and were more likely to report chronic bronchitis and exacerbations. Ever e-cigarette users had more rapid decline in lung function, but this trend did not persist after adjustment for persistent conventional cigarette smoking. E-cigarette use, which is common in adults with or at risk for COPD, was associated with worse pulmonary-related health outcomes, but not with cessation of smoking conventional cigarettes. Although this was an observational study, we find no evidence supporting the use of e-cigarettes as a harm reduction strategy among current smokers with or at risk for COPD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据